pericoach turning out to be the fringe device I always thought...

First 21 Last

Share
Profile

Follow
meerkat

21,239 Posts.

9

11/12/14

14:09

Post #: 14445534
Share

Originally posted by Jsmama ↑

To me, it doesn't matter what the detractors say. Absolutely Clueless might personally know all the women in China and know that they aren't going to use the PeriCoach, but I keep coming back to this one fact in my own mind:

I would actually buy it.

I'm female, I'm in the target age group, I've had a couple of kids. I would buy this thing at the drop of a hat if I had any symptoms whatsoever of incontinence. I wouldn't even bother going to the doctor. I would try this first.

Of course, this is a personal opinion and I also have more knowledge of the device than the general population (being a shareholder), but still, I'm a woman who would use this, if I was incontinent. If i'm peeing my pants every time I laugh or cough or if I'm at the gym lifting weights - there is no way that I wouldn't put in the time and effort (and money) to address the problem myself. If i'm going to spend $14-$20 a week on incontinence pads, then the money side of it is really a non-issue.

I have so much faith that there are many other women out there exactly like me. In my mind, the only challenge this company faces at the moment is getting the word out and given the response reportedly generated from that one little advertisement in the Women's weekly a few months ago, I think they will do quite well.

Expand

pericoach turning out to be the fringe device I always thought it would be.
Only for women who regularly perform PFE's you can forget the rest - too time consuming. People want to take a pill for their ailments not interested in hard yards.... too obvious.
For most women who'd buy it, it would end up on top of the wardrobe along with all the steak knives that looked so good on TV. LOL.

ALT Price at posting: 2.6¢ Sentiment: None Disclosure: Not Held
3 Upvote

0 Great analysis

Reply

Top Stories

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

HotCopper Highlights: Your most watched stocks for Week 46, 2024

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

First 21 Last

Add ALT (ASX) to my watchlist

pericoach turning out to be the fringe device I always thought...

Top Stories

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Banshee's historic trenches prove rich in antimony and gold for GDM

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Cyclone signs MOU with Vale for development of Iron Bear play

HotCopper Highlights: Your most watched stocks for Week 46, 2024

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Featured News